Llwytho...
Profile of ceritinib in the treatment of ALK+ metastatic non-small-cell lung cancer
Lung cancer has become one of the leading causes of death in both men and women in the United States, with approximately 230,000 new cases and 160,000 deaths each year. Approximately 80% of lung cancer patients are diagnosed with non-small-cell lung cancer (NSCLC), a subset of epithelial lung cancer...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Lung Cancer (Auckl) |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Dove Medical Press
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5217515/ https://ncbi.nlm.nih.gov/pubmed/28210149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S69114 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|